| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
56,296,000 |
| Market
Cap: |
221.24(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.07 - $5.88 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sutro Biopharma is a clinical stage drug discovery, development and manufacturing company focused on deploying its proprietary integrated cell-free protein synthesis platform, XpressCF™, to create a variety of protein therapeutics initially for cancer and autoimmune disorders. Co.'s two product candidates are wholly owned: STRO-001, an antibody-drug conjugates (ADC) directed against CD74, for patients with multiple myeloma and non-Hodgkin lymphoma; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
12,185 |
39,226 |
39,226 |
| Total Sell Value |
$0 |
$60,925 |
$186,802 |
$186,802 |
| Total People Sold |
0 |
1 |
2 |
2 |
| Total Sell Transactions |
0 |
1 |
3 |
3 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
• – – |
2023-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
85,521 |
|
- |
|
| Albini Edward C |
CFO and Secretary |
• – – |
2023-01-27 |
4 |
D |
$7.50 |
$16,050 |
D/D |
(2,140) |
30,708 |
|
- |
|
| Albini Edward C |
CFO and Secretary |
• – – |
2023-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
32,848 |
|
- |
|
| Fitzpatrick Linda A |
Chief People & Comm. Officer |
• – – |
2023-01-27 |
4 |
D |
$7.50 |
$25,230 |
D/D |
(3,364) |
41,210 |
|
- |
|
| Fitzpatrick Linda A |
Chief People & Comm. Officer |
• – – |
2023-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,250 |
44,574 |
|
- |
|
| Chung Jane |
Chief Commercial Officer |
• – – |
2022-08-09 |
4 |
D |
$6.60 |
$42,788 |
D/D |
(6,483) |
14,767 |
|
- |
|
| Chung Jane |
Chief Commercial Officer |
• – – |
2022-08-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
21,250 |
|
- |
|
| Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
• – – |
2022-07-12 |
4 |
D |
$6.08 |
$6,828 |
D/D |
(1,123) |
14,120 |
|
- |
|
| Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
• – – |
2022-07-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,250 |
15,243 |
|
- |
|
| Newell William J |
CEO |
• • – |
2022-03-14 |
4 |
B |
$7.75 |
$77,508 |
I/I |
10,000 |
116,525 |
2.66 |
-22% |
|
| Fitzpatrick Linda A |
Chief People & Comm. Officer |
• – – |
2022-03-05 |
4 |
D |
$8.17 |
$24,281 |
D/D |
(2,972) |
36,324 |
|
- |
|
| Fitzpatrick Linda A |
Chief People & Comm. Officer |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
39,296 |
|
- |
|
| Molina Arturo Md |
Chief Medical Officer |
• – – |
2022-03-05 |
4 |
D |
$8.17 |
$35,580 |
D/D |
(4,355) |
37,736 |
|
- |
|
| Molina Arturo Md |
Chief Medical Officer |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
42,091 |
|
- |
|
| Shabbir Anik |
Chief Technical Ops. Officer |
• – – |
2022-03-05 |
4 |
D |
$8.17 |
$26,144 |
D/D |
(3,200) |
27,759 |
|
- |
|
| Shabbir Anik |
Chief Technical Ops. Officer |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
30,959 |
|
- |
|
| Albini Edward C |
CFO and Secretary |
• – – |
2022-03-05 |
4 |
D |
$8.17 |
$25,695 |
D/D |
(3,145) |
27,598 |
|
- |
|
| Albini Edward C |
CFO and Secretary |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
30,743 |
|
- |
|
| Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
• – – |
2022-03-05 |
4 |
D |
$8.17 |
$34,951 |
D/D |
(4,278) |
77,817 |
|
- |
|
| Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
82,095 |
|
- |
|
| Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
• – – |
2022-03-05 |
4 |
D |
$8.17 |
$18,407 |
D/D |
(2,253) |
11,993 |
|
- |
|
| Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,500 |
14,246 |
|
- |
|
| Newell William J |
CEO |
• • – |
2022-03-05 |
4 |
D |
$8.17 |
$52,966 |
D/D |
(6,483) |
113,460 |
|
- |
|
| Newell William J |
CEO |
• • – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
119,943 |
|
- |
|
| Petree Daniel H |
Director |
– • – |
2022-02-08 |
4 |
OE |
$4.36 |
$72,564 |
D/D |
14,277 |
22,265 |
|
- |
|
221 Records found
|
|
Page 4 of 9 |
|
|
0.41 (9.45%) 
